Return to contents

ActCode
Lvl Type, Domain name and/or Mnemonic code Concept ID Mnemonic Print Name Definition/Description
1 A: ExternallyDefinedActCodes 16493
2   A: DocumentSectionType 10871 The type of document section. Possible values: review of systems, medical history, family history, microscopic findings, etc.
2   A: DocumentType 10870 The kind of document. Possible values: discharge summary, progress note, Oncology note, etc.
1 A: HL7DefinedActCodes 13954 Domain provides the root for HL7-defined detailed or rich codes for the Act classes.
2   A: AccountType 14809
3     A: CreditCard 14811
4       L:  (AE) 14814 AE American Express
4       L:  (DN) 14815 DN Diner's Club
4       L:  (DV) 14816 DV Discover Card
4       L:  (MC) 14813 MC Master Card
4       L:  (V) 14812 V Visa
3     L:  (CASH) 14810 CASH Cash
2   A: ActAlertCode 16124 Identifies types of alerts for Act class "ALRT"
3     A: ActSuppliedItemAlertCode 16656 Identifies types of alerts regarding the administration or supply of an item to a patient.
4       A: AdministrationAlertCode 16657 Administration of the proposed therapy may be inappropriate or contraindicated as proposed
5         S: ComplianceAlertCode (COMPLY) 16687 COMPLY Compliance Alert There may be an issue with the patient complying with the intentions of the proposed therapy
6           L:  (DUPTHPY) 16688 DUPTHPY Duplicate Therapy Alert The proposed drug therapy appears to duplicate an existing therapy
6           L:  (PLYDOC) 16689 PLYDOC Poly-orderer Alert A similar or identical drug therapy was recently ordered by a different provider.
6           L:  (PLYPHRM) 16690 PLYPHRM Poly-supplier Alert This patient was recently supplied a similar or identical drug therapy from a different supplier
5         S: DosageProblemAlertCode (DOSE) 16680 DOSE Dosage problem Proposed dosage instructions for drug therapy are sub-optimal or may cause patient-injury
6           S: DoseDurationAlertCode (DOSEDUR) 16684 DOSEDUR Dose-Duration Alert Proposed length of drug therapy differs from the recommended practice
7             L:  (DOSEDURH) 16686 DOSEDURH Dose-Duration High Alert Proposed length of drug therapy is longer than recommended
7             L:  (DOSEDURL) 16685 DOSEDURL Dose-Duration Low Alert Proposed length of drug therapy is shorter than that necessary for therapeutic effect
6           L:  (DOSEH) 16681 DOSEH High Dose Alert Proposed dosage exceeds recommended levels
6           L:  (DOSEIVL) 16683 DOSEIVL Dose-Interval Alert Proposed dosage interval/timing differs from the recommended practice
6           L:  (DOSEL) 16682 DOSEL Low Dose Alert Proposed dosage is below suggested therapeutic levels
5         A: DrugAppropriatenessAlertCode 16658 Drug choice may be inappropriate or contraindicated as proposed
6           A: DrugInteractionAlertCode 16659 Proposed drug therapy may interact with products that the patient may be or is taking
7             L:  (DALCH) 16663 DALCH Drug-Alcohol Interaction Proposed drug therapy may interact with alcohol
7             L:  (DDRG) 16660 DDRG Drug-Drug Interaction Alert Proposed drug therapy may interact with existing or recent drug therapy
7             L:  (DFOOD) 16662 DFOOD Drug-Food Interaction Alert Proposed drug therapy may interact with certain foods
7             L:  (DHERB) 16661 DHERB Drug-Herbal Interaction Alert Proposed drug therapy may interact with existing or recent herbal therapy
6           S: DrugObservationAlertCode (DOBS) 16664 DOBS Drug-Observation Alert Proposed drug therapy may be inappropriate or contraindicated due to conditions or characteristics of the patient
7             S: DrugConditionAlertCode (DCOND) 16665 DCOND Drug-Condition Alert Proposed drug therapy may be inappropriate or contraindicated due to an existing/recent patient condition or diagnosis
8               L:  (DLACT) 16667 DLACT Drug-Lactation Alert Proposed drug therapy may be inappropriate or contraindicated when breast-feeding
8               L:  (DPREG) 16666 DPREG Drug-Pregnancy Alert Proposed drug therapy may be inappropriate or contraindicated during pregnancy
7             S: DrugReactionAlertCode (DREACT) 16672 DREACT Drug-Reaction Alert Proposed drug therapy may be inappropriate or contraindicated based on the potential for a patient reaction to the proposed drug
8               L:  (DADR) 16675 DADR Drug-Prior Reaction Alert Proposed therapy may be inappropriate or contraindicated because of a recorded prior adverse reaction to the proposed drug
8               L:  (DALGY) 16674 DALGY Drug-Allergy Alert Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient allergy to the proposed drug. (Allergies are immune based reactions.)
8               L:  (DINT) 16673 DINT Drug-Intolerance Alert Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient intolerance to the proposed drug. (Intolerances are non-immune based sensitivities.)
7             S: RelatedDrugReactionAlertCode (RDREACT) 16676 RDREACT Related Drug-Reaction Alert Proposed drug therapy may be inappropriate or contraindicated because of a potential patient reaction to a related drug
8               L:  (RDADR) 16679 RDADR Related Drug-Prior Reaction Alert Proposed therapy may be inappropriate or contraindicated because of a recorded prior adverse reaction to a related drug
8               L:  (RDALGY) 16678 RDALGY Related Drug-Allergy Alert Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient allergy to a related drug. (Allergies are immune based reactions.)
8               L:  (RDINT) 16677 RDINT Related Drug-Intolerance Alert Proposed drug therapy may be inappropriate or contraindicated because of a recorded patient intolerance to a related drug. (Intolerances are non-immune based sensitivities.)
7             L:  (DAGE) 16669 DAGE Drug-Age Alert Proposed drug therapy may be inappropriate or contraindicated due to patient age
7             L:  (DGEN) 16671 DGEN Drug-Genetic Alert Proposed drug therapy may be inappropriate or contraindicated due to patient genetic indicators
7             L:  (DGEND) 16670 DGEND Drug-Gender Alert Proposed drug therapy may be inappropriate or contraindicated due to patient gender
7             L:  (DLAB) 16668 DLAB Drug-Lab Alert Proposed drug therapy may be inappropriate or contraindicated due to recent lab test result
4       A: SupplyAlertCode 16691 Supplying of the drug at this time may be inappropriate or indicate a compliance issues with the associated drug therapy
5         L:  (TOOLATE) 16693 TOOLATE Refill Too Late Alert This patient is receiving a second fill significantly later than would be expected based on amount previously supplied combined with therapy dosage instructions
5         L:  (TOOSOON) 16692 TOOSOON Refill Too Soon Alert This patient is receiving a second fill significantly earlier than would be expected based on amount previously supplied combined with therapy dosage instructions
2   A: ActAlertManagementCode 16695 Codes dealing with the management of Alert observations
3     S: OtherActionTakenManagementCode (08) 16703 08 Other action taken Order is performed as issued, but other action taken to mitigate potential adverse effects
4       L:  (09) 16704 09 Instituted ongoing monitoring program Arranged to monitor patient for adverse effects
4       L:  (10) 16705 10 Provided patient education Provided education or training to the patient on appropriate therapy use
4       L:  (11) 16706 11 Added concurrent therapy Instituted an additional therapy to mitigate potential negative effects
4       L:  (12) 16707 12 Temporarily suspended concurrent therapy Suspended existing therapy that triggered interaction for the duration of this therapy
4       L:  (13) 16708 13 Stopped concurrent therapy Aborted existing therapy that triggered interaction.
3     S: SupplyAppropriateManagementCode (14) 16709 14 Supply Appropriate Confirmed supply action appropriate
4       L:  (15) 16710 15 Replacement Patient's existing supply was lost/wasted
4       L:  (16) 16711 16 Vacation supply Supply date is due to patient vacation
4       L:  (17) 16712 17 Weekend Supply Supply date is intended to carry patient over weekend
3     S: TherapyAppropriateManagementCode (01) 16696 01 Therapy Appropriate Confirmed drug therapy appropriate
4       S: ConsultedPrescriberManagementCode (05) 16700 05 Consulted Prescriber Consulted prescriber, therapy confirmed
5         L:  (06) 16701 06 Prescriber Declined Change Consulted prescriber and recommended change, prescriber declined
4       L:  (02) 16697 02 Assessed Patient Assessed patient, therapy is appropriate
4       L:  (03) 16698 03 Patient Explanation Patient gave adequate explanation
4       L:  (04) 16699 04 Consulted Other Source Consulted other supply source, therapy still appropriate
4       L:  (07) 16702 07 Interacting therapy no longer active/planned Concurrent therapy triggering alert is no longer on-going or planned
2   A: ActContainerRegistrationCode 14058 Constrains the ActCode to the domain of Container Registration
3     L:  (I) 14059 I Identified used by one system to inform another that it has received a container
3     L:  (L) 14063 L Left Equipment used by one system to inform another that the container has been released from that system.
3     L:  (M) 14064 M Missing used by one system to inform another that the container did not arrive at its next expected location.
3     L:  (O) 14061 O In Process used by one system to inform another that the specific container is being processed by the equipment. It is useful as a response to a query about Container Status, when the specific step of the process is not relevant.
3     L:  (P) 14060 P In Position used by one system to inform another that the container is in position for specimen transfer (e.g., container removal from track, pipetting, etc.).
3     L:  (R) 14062 R Process Completed status is used by one system to inform another that the processing has been completed, but the container has not been released from that system.
3     L:  (X) 14065 X Container Unavailable used by one system to inform another that the container is no longer available within the scope of the system (e.g., tube broken or discarded).
2   A: ActDietCode 10376 Code set to define specialized/allowed diets
3     L:  (BR) 10379 BR breikost (GE) A diet exclusively composed of oatmeal, semolina, or rice, to be extremely easy to eat and digest.
3     L:  (DM) 10383 DM diabetes mellitus diet A diet that uses carbohydrates sparingly. Typically with a restriction in daily energy content (e.g. 1600o2000 kcal.)
3     L:  (FAST) 10382 FAST fasting No enteral intake of foot or liquids whatsoever, no smoking. Typically 6 to 8 hours before anesthesia.
3     L:  (GF) 10390 GF gluten free Gluten free diet for celiac disease.
3     L:  (LF) 10386 LF low fat A diet low in fat, particularly to patients with hepatic diseases.
3     L:  (LP) 10389 LP low protein A low protein diet for patients with renal failure.
3     L:  (LQ) 10380 LQ liquid A strictly liquid diet, that can be fully absorbed in the intestine, and therefore may not contain fiber. Used before enteral surgeries.
3     L:  (LS) 10388 LS low sodium A diet low in sodium for patients with congestive heart failure and/or renal failure.
3     L:  (N) 10377 N normal diet A normal diet, i.e. no special preparations or restrictions for medical reasons. This is notwithstanding any preferences the patient might have regarding special foods, such as vegetarian, kosher, etc.
3     L:  (NF) 10387 NF no fat A no fat diet for acute hepatic diseases.
3     L:  (PAF) 10391 PAF phenylalanine free Phenylketonuria diet.
3     L:  (PAR) 10385 PAR parenteral Patient is supplied with parenteral nutrition, typically described in terms of i.v. medications.
3     L:  (RD) 10384 RD reduction diet A diet that seeks to reduce body fat, typically low energy content (800o1600 kcal.)
3     L:  (SCH) 10378 SCH schonkost (GE) A diet that avoids ingredients that might cause digestion problems, e.g., avoid excessive fat, avoid too much fiber (cabbage, peas, beans.)
3     L:  (T) 10381 T tea only This is not really a diet, since it contains little nutritional value, but is essentially just water. Used before coloscopy examinations.
3     L:  (VLI) 10392 VLI low valine, leucine, isoleucine Diet with low content of the amino-acids valin, leucin, and isoleucin, for "maple syrup disease."
2   A: ActEncounterCode 13955 Domain provides codes that qualify the ActEncounterClass (ENC)
3     L:  (ACUTE) 13956 ACUTE inpatient acute An acute inpatient encounter.
3     L:  (AMB) 16239 AMB ambulatory An ambulatory encounter.
3     L:  (EMER) 16240 EMER emergency An emergency encounter.
3     L:  (FLD) 16235 FLD field Healthcare encounter that takes place outside a healthcare facility or home (e.g., helicopter, ambulance, accident site)
3     L:  (HH) 16237 HH home health Healthcare encounter that takes place in the residence of the patient or a designee
3     L:  (NONAC) 16238 NONAC inpatient non-acute Any category of inpatient encounter except 'acute'
3     L:  (VR) 16236 VR virtual An interaction between a practitioner and patient (or patient's agent) where the communication does not take place in person
2   A: ActIncidentCode 16508 Set of codes indicating the type of incident or accident.
3     L:  (MVA) 16509 MVA Motor vehicle accident Incident or accident is the result of a motor vehicle accident
3     L:  (WPA) 16510 WPA Workplace accident Incident or accident is the result of a work place accident
2   A: ActLabObsCode 13957 Provides an abstract root class for laboratory observations
3     A: ActLabObsArtBldCode 14387 Domain provides codes that qualify the ActLabObsArtBldCode domain. (Artificial Blood)
4       L:  (FLUR) 14389 FLUR Fluorocarbons Refines Artificial Blood
4       L:  (SFHB) 14388 SFHB Stromal free hemoglobin preparations Refines Artificial Blood
3     A: ActLabObsDilutionCode 14352 Domain provides codes that qualify the ActLabObsDilutionCode domain.
4       L:  (AUTO-HIGH) 13958 AUTO-HIGH Auto-High Dilution Refines dilution
4       L:  (AUTO-LOW) 13959 AUTO-LOW Auto-Low Dilution Refines dilution
4       L:  (PRE) 13961 PRE Pre-Dilution Refines dilution
4       L:  (RERUN) 13960 RERUN Rerun Dilution Refines dilution
3     A: ActLabObsEvnfctsCode 14390 Domain provides codes that qualify the ActLabObsEnvfctsCode domain. (Environmental Factors)
4       L:  (A60) 14392 A60 Opened container, indoor atmosphere, 60 minutes du Refines Environmental Factors
4       L:  (ATM) 14391 ATM Opened container, atmosphere/duration unspecified Refines Environmental Factors
3     A: ActLabObsInterferenceCode 14382 Domain provides codes that qualify the ActLabObsInterferenceCode domain.
4       L:  (FIBRIN) 14386 FIBRIN Fibrin Refines Interference
4       L:  (HEMOLYSIS) 14383 HEMOLYSIS Hemolysis Refines Interference
4       L:  (ICTERUS) 14385 ICTERUS Icterus Refines Interference
4       L:  (LIPEMIA) 14384 LIPEMIA Lipemia Refines Interference
3     A: ActLabObsVolumeCode 14369 Domain provides codes that qualify the ActLabObsVolumeCode domain.
4       L:  (AVAILABLE) 13963 AVAILABLE Available Volume Refines VOLUME
4       L:  (CONSUMPTION) 13965 CONSUMPTION Consumption Volume Refines VOLUME
4       L:  (CURRENT) 13962 CURRENT Current Volume Refines VOLUME
4       L:  (INITIAL) 13964 INITIAL Initial Volume Refines VOLUME
2   A: ActMonitoringProtocolCode 16231 Identifies types of monitoring programs
3     S: ControlledSubstanceMonitoringProtocol (CTLSUB) 16232 CTLSUB Controlled Substance A monitoring program that focuses on narcotics and/or commonly abused substances that are subject to legal restriction.
2   A: ActPharmacySupplyType 16208 Identifies types of dispensing events
3     S: EmergencyPharmacySupplyType (EM) 16220 EM Emergency Supply A supply action where there is no 'valid' order for the supplied medication. E.g. Emergency vacation supply, weekend supply (when prescriber is unavailable to provide a renewal prescription)
4       L:  (SO) 16221 SO Script Owing An emergency supply where the expectation is that a formal order authorizing the supply will be provided at a later date.
3     S: FirstFillPharmacySupplyType (FF) 16209 FF First Fill The initial fill against an order. (This includes initial fills against refill orders.)
4       L:  (FFC) 16210 FFC First Fill - Complete A first fill where the quantity supplied is equal to one full reptition of the ordered amount. (e.g. If the order was 90 tablets, 3 refills, a complete fill would be for the full 90 tablets.)
4       L:  (FFP) 16211 FFP First Fill - Part Fill A first fill where the quantity supplied is less than one full reptition of the ordered amount. (e.g. If the order was 90 tablets, 3 refills, a partial fill might be for only 30 tablets.)
3     S: RefillPharmacySupplyType (RF) 16215 RF Refill A fill against an order that has already been filled (or partially filled) at least once.
4       L:  (RFC) 16216 RFC Refill - Complete A refill where the quantity supplied is equal to one full reptition of the ordered amount. (e.g. If the order was 90 tablets, 3 refills, a complete fill would be for the full 90 tablets.)
4       L:  (RFF) 16218 RFF Refill (First fill this facility) The first fill against an order that has already been filled at least once at another facility.
4       L:  (RFP) 16217 RFP Refill - Part Fill A refill where the quantity supplied is less than one full reptition of the ordered amount. (e.g. If the order was 90 tablets, 3 refills, a partial fill might be for only 30 tablets.)
3     L:  (DF) 16214 DF Daily Fill A fill providing sufficient supply for one day
3     L:  (FS) 16222 FS Floor stock A supply action to restock a smaller more local dispensary.
3     L:  (MS) 16219 MS Manufacturer Sample A supply of a manufacturer sample
3     L:  (TB) 16213 TB Trial Balance A fill where the remainder of a 'complete' fill is provided after a trial fill has been provided.
3     L:  (TF) 16212 TF Trial Fill A fill where a small portion is provided to allow for determination of the therapy effectiveness and patient tolerance.
3     L:  (UD) 16223 UD Unit Dose A supply action that provides sufficient material for a single dose.
2   A: ActProcedureCode 16535 The type of procedure Act
2   A: ActSpecimenTreatmentCode 14040 Set of codes related to specimen treatments
3     L:  (ACID) 14044 ACID Acidification The lowering of specimen pH through the addition of an acid
3     L:  (ALK) 14046 ALK Alkalization The act rendering alkaline by impregnating with an alkali; a conferring of alkaline qualities.
3     L:  (DEFB) 14043 DEFB Defibrination The removal of fibrin from whole blood or plasma through physical or chemical means
3     L:  (FILT) 14047 FILT Filtration The passage of a liquid through a filter, accomplished by gravity, pressure or vacuum (suction).
3     L:  (LDLP) 14041 LDLP LDL Precipitation
3     L:  (NEUT) 14045 NEUT Neutralization The act or process by which an acid and a base are combined in such proportions that the resulting compound is neutral.
3     L:  (RECA) 14042 RECA Recalcification The addition of calcium back to a specimen after it was removed by chelating agents
3     L:  (UFIL) 14048 UFIL Ultrafiltration The filtration of a colloidal substance through a semipermeable medium that allows only the passage of small molecules.
2   A: EncounterAccomodation 16130
3     L:  (I) 16134 I isolation Accomodations used in the case of diseases that are transmitted through casual contact or respiratory transmission.
3     L:  (P) 16131 P private Accommodations in which the patient is the sole occupant.
3     L:  (S) 16133 S suite Uniquely designed and elegantly decorated accomodations with many amenities available for an additional charge.
3     L:  (SP) 16132 SP semi-private Accommodations in which the patient shares occupancy with one other patient.
3     L:  (W) 16135 W ward Accommodations in which more than two patients are receiving care.
2   A: FinancialTransactionType 14804
3     L:  (CHRG) 14805 CHRG Standard Charge
3     L:  (REV) 14806 REV Standard Charge Reversal
2   A: ReferencedCoordinateRegionType 16117 Shape of the region on the object being referenced
3     L:  (CIRCLE) 16118 CIRCLE circle A circle defined by two (column,row) pairs. The first point is the center of the circle and the second point is a point on the perimeter of the circle.
3     L:  (ELLIPSE) 16119 ELLIPSE ellipse An ellipse defined by four (column,row) pairs, the first two points specifying the endpoints of the major axis and the second two points specifying the endpoints of the minor axis.
3     L:  (POINT) 16120 POINT point A single point denoted by a single (column,row) pair, or multiple points each denoted by a (column,row) pair.
3     L:  (POLY) 16121 POLY polyline A series of connected line segments with ordered vertices denoted by (column,row) pairs; if the first and last vertices are the same, it is a closed polygon.
2   A: SubstanceAdministrationActCode 16532 The specific chemical or radiological substance administered or to be administered into the body for therapeutic effect.
3     A: ClinicalDrug 16205 A substance or use of a substance whose therapeutic effect is produced by chemical action within the body.
4       A: ManufacturedDrug 16206 Identifies a drug or the use of a drug as produced by a specific manufacturer
1 A: ObservationType 16226 Identifies the kinds of observations that can be performed
2   A: LogicalObservationIdentifierNamesAndCodes 16492 The LOINC database provides a set of universal names and ID codes for identifying laboratory and clinical test results. The purpose is to facilitate the exchange and pooling of results, such as blood hemoglobin, serum potassium, or vital signs, for clinical care, outcomes management, and research. The LOINC codes are not intended to transmit all possible information about a test or observation. They are only intended to identify the test result or clinical observation. http://www.regenstrief.org/LOINC/LOINC.htm
2   A: ObservationDiagnosisTypes 16228 Identifies the kinds of diagnosis observations that can be performed
2   L:  (SEV) 16642 SEV Severity Observation Indicates a subjective evaluation of the criticality associated with another observation.

Return to contents